Delivery Order SPE2DR25D1201-SPE2DR26FAKRN
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $14,078.93 on January 20, 2026, to supply Jardiance 25 mg tablets (90-count) to the Defense Logistics Agency with an ultimate completion date of January 21, 2026. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. This delivery order is issued under...
- The Defense Logistics Agency awarded a $105,814.93 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) with an ultimate completion date of January 23, 2026. This contract was awarded on a non-set-aside, competitive basis to the Conshohocken, Pennsylvania-based pharmaceutical distributor, a subsidiary of parent company Cencora, Inc. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order valued at $15,594.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 20, 2026, with a completion date of January 21, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the vendor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $40,210.31 to AmerisourceBergen Drug Corp on November 3, 2025, for the supply of Jardiance 10 mg tablets in quantities of 90 units. This is a firm fixed-price delivery order with no set-aside designation, executed under open competition. The order is scheduled for completion by November 4, 2025, with performance at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. The delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $21,473.87 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 22, 2026, with completion scheduled for January 23, 2026. This competitive award, structured as a firm fixed-price delivery order with no set-aside designation, represents a task order under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located in...
- The Defense Logistics Agency awarded a delivery order valued at $11,643.53 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) with a completion date of December 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's substantial pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $10,756.42 to AmerisourceBergen Drug Corp for the supply of Jardiance 10mg tablets (90-count) on November 18, 2025, with completion scheduled for December 16, 2025. This firm fixed-price, non-set-aside contract will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a delivery order valued at $18,522.20 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on January 28, 2026, with completion expected by January 29, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc., a major...
- The Defense Logistics Agency awarded a delivery order valued at $10,383.05 to AmerisourceBergen Drug Corp on January 14, 2026, for the supply of Jardiance 10 mg tablets (90-count units). This is a firm fixed-price, non-competitive delivery order with an ultimate completion date of January 15, 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, fulfills this order from its corporate office location. The company operates as a...
- The Defense Logistics Agency awarded a delivery order valued at $2,879.86 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count) on January 28, 2026, with an ultimate completion date of January 29, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under the company's...
- SPE2DR25D1201Indefinite Delivery Contract
- SPE2DR25D1201-SPE2DR26FAKRNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $43,104.56 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count packaging) on January 29, 2026. This firm fixed-price delivery order, which carries a completion deadline of January 30, 2026, was competitively awarded with no set-aside designation. The contract is performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, the company's headquarters and distribution hub. This delivery order operates under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 through December 2031. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor supporting federal military and healthcare systems through its extensive portfolio of medications and medical supplies. This particular order for Jardiance, a diabetes management medication, exemplifies the company's role in supplying prescription pharmaceuticals across multiple therapeutic domains to Defense Health Agency and other government healthcare programs. The competitively awarded delivery order reflects AmerisourceBergen's demonstrated capability to fulfill federal procurement requirements and maintain the supply chain for essential medications supporting military treatment facilities and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.1k | 1/28/26 |